ER-Golgi network--a future target for anti-cancer therapy.
about
GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapyProtein kinases and phosphatases in the control of cell fateOrganelle targeting: third level of drug targetingViolacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapseAmpelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathwayBicPAM: Pattern-based biclustering for biomedical data analysis.Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Prognosis in Colorectal Cancers.The asymmetrical structure of Golgi apparatus membranes revealed by in situ atomic force microscope.Texosome-anchored superantigen triggers apoptosis in original ovarian cancer cells.Computational analysis of the roles of ER-Golgi network in the cell cycle.Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signalingDiscerning the Chemistry in Individual Organelles with Small-Molecule Fluorescent Probes.Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers.Cigarette Smoking Condensate Disrupts Endoplasmic Reticulum-Golgi Network Homeostasis Through GOLPH3 Expression in Normal Lung Epithelial Cells.Ultraviolet (UV) and hydrogen peroxide activate ceramide-ER stress-AMPK signaling axis to promote retinal pigment epithelium (RPE) cell apoptosis.Endoplasmic reticulum-Golgi intermediate compartment protein 3 knockdown suppresses lung cancer through endoplasmic reticulum stress-induced autophagy.Preclinical study of cinobufagin as a promising anti-colorectal cancer agent.Microfluidic cell arrays in tumor analysis: new prospects for integrated cytomics.Secretory pathway stress responses as possible mechanisms of disease involving Golgi Ca2+ pump dysfunctionGOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis.Cell-penetrating peptides with intracellular organelle targeting.Cytotoxic mechanisms of panduratin A on A375 melanoma cells: A quantitative and temporal proteomics analysis.A Nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-2.Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivoCellular uptake mechanisms of an antitumor ruthenium compound: the endosomal/lysosomal system as a target for anticancer metal-based drugs.ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells.Controlling and Monitoring Intracellular Delivery of Anticancer Polymer Nanomedicines.Activity of different anthracycline formulations in hormone-refractory prostate cancer cell lines: role of Golgi apparatus.Microfluidics: Emerging prospects for anti-cancer drug screening.Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress-inducing agents.GOLM1-regulated EGFR/RTK recycling is a novel target for combating HCC metastasis.An integrated approach to infer cross-talks between intracellular protein transport and signaling pathways.Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
P2860
Q24338965-792A0334-FDED-4A14-824C-21A08E27E4F6Q24604987-DB3DD93E-6331-4631-9F9F-CE0BD3B58F3AQ27014902-5278A79C-7E92-4F79-B772-4D5255242E7DQ28484370-C61537CA-683B-4811-84D8-044574FA89B8Q28539792-6AD33691-6455-4EC1-AE2F-ED5ED115744BQ30887396-4452BD77-987C-419E-B679-7CD454516159Q33820607-8255A3DA-884D-425C-BD6C-5200338A4B38Q34341051-96240824-0DA6-42D9-A649-97422E85F1D6Q35468936-F63D6090-B951-4E8A-B5B6-0083E4A05B80Q35529741-89ABCA59-6089-4C2A-8F47-BE3229961A05Q35742493-73FCDE27-4316-4B50-B432-DADF405DC9F9Q36115905-C3CB95F9-C39B-4E70-A926-54D1044DCE1CQ36127827-7C9933FD-2FF4-414D-A5F8-0355619A32ADQ36127983-9AE784E7-97A9-458E-A414-8BCD6F3B8817Q36913748-2BBAB1AC-E7A9-4404-9899-00C0549CC8B8Q37662233-B0F7CD1D-8FFC-4E41-BA4E-6B1EDCD03CEAQ37702397-BEE239B4-270C-4380-B358-8A786F7F1586Q37750876-1FD6EFB9-A4F7-44E2-BE91-D061F0919DEEQ37889805-B9AFF0D3-AF88-4DE4-8A61-B6F28BE25836Q38749499-CFFE9057-43A5-4F80-A0E8-27BC118E9759Q38900020-7EBE86C2-DFBC-4C6F-B5C3-30F53450FE35Q38919337-A2DC8257-84A2-458A-BDC9-CB237E267F39Q38937824-72942377-34C1-4289-B73F-11360F93F358Q38953684-781E3C8B-EB74-4314-98B7-9A71BD2E829CQ39136843-BBBB4B13-A021-44D2-A269-30BBF29E47D7Q39167609-314BB4B5-1C8E-494C-B6F9-3A4DF6AD6051Q39264057-91D12B9C-DF91-456A-BE15-1F89BD073541Q39596127-89CB2644-334B-4ABF-B824-33200EB2841DQ42042125-C2DF7AC4-2F06-4291-8BEE-B47B5A54F9B6Q48170630-290A24E9-4EDA-434E-8552-146E355CB773Q51321067-05120CF7-51B9-41D6-91B6-033CA65A2963Q52356479-0B1E3644-F7CD-4BE4-B0B4-3E59280FB944Q52690584-AF70FCB8-8E29-4E40-ADB6-6AB0E951519E
P2860
ER-Golgi network--a future target for anti-cancer therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
ER-Golgi network--a future target for anti-cancer therapy.
@en
ER-Golgi network--a future target for anti-cancer therapy.
@nl
type
label
ER-Golgi network--a future target for anti-cancer therapy.
@en
ER-Golgi network--a future target for anti-cancer therapy.
@nl
prefLabel
ER-Golgi network--a future target for anti-cancer therapy.
@en
ER-Golgi network--a future target for anti-cancer therapy.
@nl
P2860
P50
P1433
P1476
ER-Golgi network--a future target for anti-cancer therapy.
@en
P2093
Chris Hillier
Dagmara McGuinness
P2860
P304
P356
10.1016/J.LEUKRES.2009.05.025
P577
2009-11-01T00:00:00Z